Due to a measles case in the community, please call before coming to Seattle Children’s if you or your child has potential measles symptoms.

Current Research Studies

Pediatric Options for Migraine Relief: A Randomized, Double-Blind, Placebo-Controlled Study of Lasmiditan for Acute Treatment of Migraine: PIONEER-PEDS1

LAHV_Pioneer_1

Phase: III
Clinicaltrials.gov ID: NCT04396236

What is the goal of the study?

This study is being done to see how safe lasmiditan is and how well it will work to help people with migraines. This study will see how lasmiditan compares to placebo for treating migraine attacks in young people.

Who can participate in the study?

This study may be a good fit for children who: Are at least 6 years old and less than 18 years old at Visit 1 Weigh at least 15 kilograms Have been diagnosed with migraines Can swallow tablets You and your family agree not to post information about the study on any website or on social media

Study Team:

PI (Study Doctor): Heidi Blume
Study Team Member: Mikaela Gatterman, Mikaela.Gatterman@seattlechildrens.org

Seattle Children’s complies with applicable federal and other civil rights laws and does not discriminate, exclude people or treat them differently based on race, color, religion (creed), sex, gender identity or expression, sexual orientation, national origin (ancestry), age, disability, or any other status protected by applicable federal, state or local law. Financial assistance for medically necessary services is based on family income and hospital resources and is provided to children under age 21 whose primary residence is in Washington, Alaska, Montana or Idaho.